CYP3A7
Reactivité: Humain
WB
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Western Blot (1-2 μg/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1-5 μg/mL) The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Format
Liquid
Buffer
In PBS (0.08 % sodium azide)
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Store at -20°C. Aliquot to avoid repeated freezing and thawing.
Kumarakulasingham, Rooney, Dundas, Telfer, Melvin, Curran, Murray: "Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 11, Issue 10, pp. 3758-65, (2005) (PubMed).
Leeder, Gaedigk, Marcucci, Gaedigk, Vyhlidal, Schindel, Pearce: "Variability of CYP3A7 expression in human fetal liver." dans: The Journal of pharmacology and experimental therapeutics, Vol. 314, Issue 2, pp. 626-35, (2005) (PubMed).
Ogino, Nagata, Yamazoe: "Selective suppressions of human CYP3A forms, CYP3A5 and CYP3A7, by troglitazone in HepG2 cells." dans: Drug metabolism and pharmacokinetics, Vol. 17, Issue 1, pp. 42-6, (2004) (PubMed).
Antigène
CYP3A7
(Cytochrome P450, Family 3, Subfamily A, Polypeptide 7 (CYP3A7))